Join Our Telegram channel to stay up to date on breaking news coverage
Following China’s pharma scandal, investors are buying a firm’s claim to be developing a vaccine-tracking blockchain, but one regulator isn’t happy.
Join Our Telegram channel to stay up to date on breaking news coverage